Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Osteosarcoma × palbociclib × Clear all

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Estrogen Receptor-positive Breast Cancer 2 Thyroid Neoplasms 1 Thymus Neoplasms 1 Thrombosis 1 Thromboembolism 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Lung Neoplasms 1 Inflammation 1 Immune System Diseases 1 HER2+ Breast Cancer 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 ER Positive, HER2 Negative Breast Cancer 1 Colonic Neoplasms 1 Chordoma 1 Cardiovascular Diseases 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors 1 Breast Diseases 1 Brain Neoplasms 1

Interventions

Drug Therapy 5 Methotrexate 4 apatinib 3 Neoadjuvant Therapy 3 camrelizumab 2 Ifosfamide 2 Doxorubicin 2 trilaciclib 1 spartalizumab 1 palbociclib 1 irinotecan sucrosofate 1 glucarpidase 1 endostar protein 1 Zoledronic Acid 1 Vinorelbine 1 Triptorelin Pamoate 1 Trabectedin 1 Therapeutics 1 TQ-B3525 1 Psychiatric Rehabilitation 1 Nivolumab 1 Neuropsychological Tests 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Ipilimumab 1 Immune Checkpoint Inhibitors 1 Gelclair 1 Everolimus 1 Cyclophosphamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03242382 2024-01-23

PalboSarc

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown

Chordoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡